Şinasi Özsoylu
Objective: Multiple myeloma (MM) has a better survival outcome because of the development of drugs. However, equivalent outcomes cannot be expected from the same drug. Therefore, how the treatment schedule is managed is...
Şinasi Özsoylu (2015). Mikroanjiopatik Hemolitik Anemi Üzerine. Turkish Journal of Hematology, 32(1), 92-92. https://europub.co.uk./articles/-A-105725
For faster login or register use your social account.
Dose Adjustment Helps Obtain Better Outcomes in Multiple Myeloma Patients with Bortezomib, Melphalan, and Prednisolone (VMP) Treatment
Objective: Multiple myeloma (MM) has a better survival outcome because of the development of drugs. However, equivalent outcomes cannot be expected from the same drug. Therefore, how the treatment schedule is managed is...
Talasemi İntermedia ve Akut Lenfoblastik Lösemi Rastlantısal Çift Tanı mı?
Acquired Hemophilia
Interstitial Pneumonitis in a Patient with Chronic Myeloid Leukemia
HBV ve HCV Koenfeksiyonu ile İlişkili Sıcak Tip Otoimmün Hemolitik Anemi: Bir Olgu Sunumu